Australia markets closed

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.62-1.47 (-7.70%)
At close: 04:00PM EST
17.62 0.00 (0.00%)
After hours: 07:58PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
38,438
0
0
0
Operating expenses
Research development
218,421
192,987
144,535
151,860
Selling general and administrative
71,278
65,256
57,473
40,982
Total operating expenses
289,699
258,243
202,008
192,842
Operating income or loss
-251,261
-258,243
-202,008
-192,842
Interest expense
-
0
0
3,358
Total other income/expenses net
-2,532
-1,142
-268
-21,211
Income before tax
-250,707
-250,221
-184,925
-211,622
Income tax expense
-
0
-331
-117
Income from continuing operations
-250,707
-250,221
-184,594
-211,505
Net income
-250,707
-250,221
-184,594
-211,505
Net income available to common shareholders
-250,707
-250,221
-184,594
-211,505
Basic EPS
-
-2.08
-1.83
-7.31
Diluted EPS
-
-2.08
-1.83
-7.31
Basic average shares
-
120,370
101,061
28,948
Diluted average shares
-
120,370
101,061
28,948
EBITDA
-
-242,635
-179,898
-206,764